Big Pharma, Little Science? A Bibliometric Perspective On Big Pharma’s R&D Decline
Cold Dark Matter: Controversies On Small Scales
This story is only available to subscribers.
Don’t settle for half the story.
Get paywall-free access to technology news for the here and now.